TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Pact Pharma Stock

Pact Pharma Stock

pactpharma.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $354.6MM

PACT Pharma clinical stage biotechnology company developing personalized adoptive T cell therapies for the eradication of solid tumors.

Learn more about Pact Pharma IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Pact Pharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Pact Pharma’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Pact Pharma.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Alex Franzusoff Ph.D
Chief Scientific Officer
Antoni Ribas Ph.D
Scientific Co-Founder & Board Member
Timothy Moore
Chief Technical Officer & President
Juan Jaen Ph.D
Co-Founder & Board Member
James Heath Ph.D
Scientific Co-Founder & Board Member
David Baltimore Ph.D
Scientific Co-Founder & Chairman of Scientific Advisory Board
Terry Rosen Ph.D
Co-Founder & Board Member
Blake Byers Ph.D
Interim President & Board Member

Board Members

Antoni Ribas Ph.D
Juan Jaen Ph.D
Terry Rosen Ph.D
David Baltimore Ph.D
James Heath Ph.D
Blake Byers Ph.D
KT Moortgat Ph.D
AbbVie Ventures

Other companies like Pact Pharma in the BioTech & Pharma sector

Egenesis

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$387.57MM

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Prime Medicine

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.23B

ADARx Pharmaceuticals

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$827.77MM

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.7B

Pendulum Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM

Cytonics

Sector
Healthcare / BioTech & Pharma
 
 

AI Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM

News Highlights

FINSMES 01/13/2020
PACT Pharma Secures $75M in Series C Financing | FinSMEs
PACT Pharma, a SouthSan Francisco, Calif.-based advancing personalized NeoTCR-T cell therapies to eradicate solid tumors, closed a $75m Series C financing
PE Hub 10/02/2019
VC-backed PACT Pharma taps Moore as president and CTO | PE Hub
South San Francisco-based PACT Pharma, a provider of personalized cell therapy for solid tumors, has appointed Tim Moore as president and chief technical officer. Previously, Moore worked at Kite where he was executive vice president of technical operations. PACT Pharma's backers included GV, Canaan, Casdin Capital, Droia, Foresite Capital, Invus, Pontifax, Wu Capital, AbbVie Ventures and Taiho Ventures.

Trending Companies

Frequently Asked Questions

Updated on: Apr 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.